ArticleJournal of cancer research and clinical oncology2023

Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC.

Xiao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.